Eady E Anne, Cove Jonathan H
School of Biochemistry and Molecular Biology, University of Leeds, UK.
Curr Opin Infect Dis. 2003 Apr;16(2):103-24. doi: 10.1097/00001432-200304000-00007.
In the community non-localized or deep staphylococcal skin and soft tissue infections are typically managed with beta-lactamase stable penicillins. The aims of this review are (1) to evaluate the evidence for the emergence of new strains of community-acquired methicillin resistant Staphylococcus aureus (MRSA), (2) to identify the reasons for their significant association with cutaneous infections, and (3) to consider how they arose and how big a threat they pose to the management of such infections outside hospitals.
MRSA are emerging as significant community pathogens, especially in previously healthy children with no recognizable risk factors, and are predominantly associated with skin and soft tissue infections (especially abscesses and cellulitis). When present, risk factors are generally similar to those for infection with methicillin susceptible S. aureus. The MRSA isolates associated with such infections may not be entirely 'new', but could represent the displacement of some hospital clones (e.g. EMRSA-15 or variants thereof) to the community as well as the de-novo generation of novel MRSA clones by multiple horizontal transmissions of the mecA gene into methicillin susceptible S. aureus with different genetic backgrounds, some of which are already circulating globally. Community-acquired MRSA from diverse locations are non multiresistant and almost always contain the novel type IV SCCmec commonly found in coagulase-negative staphylococci, but also in hospital-associated gentamicin susceptible MRSA from France, the paediatric clone and in EMRSA-15.
More local data on CA-MRSA infections are needed so that dermatologists and community physicians can assess the risk of such infections amongst their patients and avoid the inappropriate administration of beta-lactams. No simple change in prescribing practices will entirely alleviate selective pressure for the spread of community-acquired MRSA and not exacerbate resistance in pyogenic streptococci, commonly found together with S. aureus in skin and soft tissue infections. The importance of hygiene in preventing the spread of community-acquired MRSA in the community must be reemphasized.
在社区中,非局限性或深部葡萄球菌皮肤和软组织感染通常用对β-内酰胺酶稳定的青霉素进行治疗。本综述的目的是:(1)评估社区获得性耐甲氧西林金黄色葡萄球菌(MRSA)新菌株出现的证据;(2)确定它们与皮肤感染显著相关的原因;(3)思考它们是如何产生的,以及它们对医院外此类感染的治疗构成多大威胁。
MRSA正成为重要的社区病原体,尤其是在没有明显危险因素的既往健康儿童中,并且主要与皮肤和软组织感染(尤其是脓肿和蜂窝织炎)相关。存在危险因素时,通常与甲氧西林敏感金黄色葡萄球菌感染的危险因素相似。与此类感染相关的MRSA分离株可能并非完全“新出现”的,而是可能代表一些医院克隆株(如EMRSA-15或其变体)向社区的转移,以及通过mecA基因多次水平转移到具有不同遗传背景的甲氧西林敏感金黄色葡萄球菌中产生新的MRSA克隆株,其中一些已在全球传播。来自不同地区的社区获得性MRSA并非多重耐药,几乎总是含有通常在凝固酶阴性葡萄球菌中发现的新型IV型SCCmec,也存在于法国医院相关的庆大霉素敏感MRSA、儿科克隆株和EMRSA-15中。
需要更多关于社区获得性MRSA感染的本地数据,以便皮肤科医生和社区医生能够评估其患者中此类感染的风险,并避免不恰当地使用β-内酰胺类药物。处方习惯的简单改变并不能完全减轻社区获得性MRSA传播的选择性压力,也不会加剧化脓性链球菌的耐药性,化脓性链球菌通常与金黄色葡萄球菌一起存在于皮肤和软组织感染中。必须再次强调卫生在预防社区获得性MRSA在社区传播中的重要性。